218 related articles for article (PubMed ID: 11907113)
1. Tumor regression induced by intratumor therapy with a disabled infectious single cycle (DISC) herpes simplex virus (HSV) vector, DISC/HSV/murine granulocyte-macrophage colony-stimulating factor, correlates with antigen-specific adaptive immunity.
Ali SA; Lynam J; McLean CS; Entwisle C; Loudon P; Rojas JM; McArdle SE; Li G; Mian S; Rees RC
J Immunol; 2002 Apr; 168(7):3512-9. PubMed ID: 11907113
[TBL] [Abstract][Full Text] [Related]
2. Regulation of CTL responses to MHC-restricted class I peptide of the gp70 tumour antigen by splenic parenchymal CD4+ T cells in mice failing immunotherapy with DISC-mGM-CSF.
Ahmad M; Rees RC; McArdle SE; Li G; Mian S; Entwisle C; Loudon P; Ali SA
Int J Cancer; 2005 Jul; 115(6):951-9. PubMed ID: 15723299
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.
Ali SA; McLean CS; Boursnell ME; Martin G; Holmes CL; Reeder S; Entwisle C; Blakeley DM; Shields JG; Todryk S; Vile R; Robins RA; Rees RC
Cancer Res; 2000 Mar; 60(6):1663-70. PubMed ID: 10749137
[TBL] [Abstract][Full Text] [Related]
4. Oncolytic viral therapy with a combination of HF10, a herpes simplex virus type 1 variant and granulocyte-macrophage colony-stimulating factor for murine ovarian cancer.
Goshima F; Esaki S; Luo C; Kamakura M; Kimura H; Nishiyama Y
Int J Cancer; 2014 Jun; 134(12):2865-77. PubMed ID: 24265099
[TBL] [Abstract][Full Text] [Related]
5. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
6. Trafficking of tumor peptide-specific cytotoxic T lymphocytes into the tumor microcirculation.
Ali S; Ahmad M; Lynam J; Rees RC; Brown N
Int J Cancer; 2004 Jun; 110(2):239-44. PubMed ID: 15069688
[TBL] [Abstract][Full Text] [Related]
7. Disabled infectious single-cycle herpes simplex virus as an oncolytic vector for immunotherapy of colorectal cancer.
Todryk S; McLean C; Ali S; Entwistle C; Boursnell M; Rees R; Vile R
Hum Gene Ther; 1999 Nov; 10(17):2757-68. PubMed ID: 10584922
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic virotherapy with an HSV amplicon vector expressing granulocyte-macrophage colony-stimulating factor using the replication-competent HSV type 1 mutant HF10 as a helper virus.
Kohno SI; Luo C; Nawa A; Fujimoto Y; Watanabe D; Goshima F; Tsurumi T; Nishiyama Y
Cancer Gene Ther; 2007 Nov; 14(11):918-26. PubMed ID: 17693992
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapeutic potential of DISC-HSV and OX40L in cancer.
Assudani DP; Ahmad M; Li G; Rees RC; Ali SA
Cancer Immunol Immunother; 2006 Jan; 55(1):104-11. PubMed ID: 16001161
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumour therapeutic efficacy of OX40L in murine tumour model.
Ali SA; Ahmad M; Lynam J; McLean CS; Entwisle C; Loudon P; Choolun E; McArdle SE; Li G; Mian S; Rees RC
Vaccine; 2004 Sep; 22(27-28):3585-94. PubMed ID: 15315837
[TBL] [Abstract][Full Text] [Related]
11. Combined suicide and granulocyte-macrophage colony-stimulating factor gene therapy induces complete tumor regression and generates antitumor immunity.
Jones RK; Pope IM; Kinsella AR; Watson AJ; Christmas SE
Cancer Gene Ther; 2000 Dec; 7(12):1519-28. PubMed ID: 11228530
[TBL] [Abstract][Full Text] [Related]
12. Endogenous granulocyte-macrophage colony-stimulating factor overexpression in vivo results in the long-term recruitment of a distinct dendritic cell population with enhanced immunostimulatory function.
Miller G; Pillarisetty VG; Shah AB; Lahrs S; Xing Z; DeMatteo RP
J Immunol; 2002 Sep; 169(6):2875-85. PubMed ID: 12218100
[TBL] [Abstract][Full Text] [Related]
13. In situ recruitment of antigen-presenting cells by intratumoral GM-CSF gene delivery.
Pan PY; Li Y; Li Q; Gu P; Martinet O; Thung S; Chen SH
Cancer Immunol Immunother; 2004 Jan; 53(1):17-25. PubMed ID: 12955480
[TBL] [Abstract][Full Text] [Related]
14. Irradiated tumor cells adenovirally engineered to secrete granulocyte/macrophage-colony-stimulating factor establish antitumor immunity and eliminate pre-existing tumors in syngeneic mice.
Nagai E; Ogawa T; Kielian T; Ikubo A; Suzuki T
Cancer Immunol Immunother; 1998 Oct; 47(2):72-80. PubMed ID: 9769115
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte-macrophage colony-stimulating factor-based melanoma cell vaccines immunize syngeneic and allogeneic recipients via host dendritic cells.
Schneeberger A; Lührs P; Kutil R; Steinlein P; Schild H; Schmidt W; Stingl G
J Immunol; 2003 Nov; 171(10):5180-7. PubMed ID: 14607918
[TBL] [Abstract][Full Text] [Related]
16. Local Delivery of OncoVEX
Moesta AK; Cooke K; Piasecki J; Mitchell P; Rottman JB; Fitzgerald K; Zhan J; Yang B; Le T; Belmontes B; Ikotun OF; Merriam K; Glaus C; Ganley K; Cordover DH; Boden AM; Ponce R; Beers C; Beltran PJ
Clin Cancer Res; 2017 Oct; 23(20):6190-6202. PubMed ID: 28706012
[No Abstract] [Full Text] [Related]
17. Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte response.
Chiodoni C; Paglia P; Stoppacciaro A; Rodolfo M; Parenza M; Colombo MP
J Exp Med; 1999 Jul; 190(1):125-33. PubMed ID: 10429676
[TBL] [Abstract][Full Text] [Related]
18. An M2 Rather than a T
Lee DH; Ghiasi H
J Virol; 2018 May; 92(10):. PubMed ID: 29491152
[TBL] [Abstract][Full Text] [Related]
19. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.
Hill HC; Conway TF; Sabel MS; Jong YS; Mathiowitz E; Bankert RB; Egilmez NK
Cancer Res; 2002 Dec; 62(24):7254-63. PubMed ID: 12499267
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast cancer model.
Majumdar AS; Zolotorev A; Samuel S; Tran K; Vertin B; Hall-Meier M; Antoni BA; Adeline E; Philip M; Philip R
Cancer Gene Ther; 2000 Jul; 7(7):1086-99. PubMed ID: 10917212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]